To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

End-Stage Renal Disease Requiring Haemodialysis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Peking University People's Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Li Zuo, Doctor) · zuoli@bjmu.edu.cn
Study leads
  • Li Zuo, Doctor

    Principal Investigator

    Peking University People's Hospital

  • Yuqing Chen

    Principal Investigator

    Peking University First Hospital